{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T01:26:45Z","timestamp":1791163605713,"version":"4.1.0"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2011,7,19]],"date-time":"2011-07-19T00:00:00Z","timestamp":1311033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100005689","name":"Medical Society of G\u00f6teborg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005689","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Swedish Association against Rheumatism"},{"name":"King Gustaf V:s Foundation"},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Professor Nanna Swartz Foundation"},{"name":"AME Wolff Foundation"},{"name":"Rune and Ulla Aml\u00f6vs Trust"},{"DOI":"10.13039\/501100001729","name":"Swedish Foundation for Strategic Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001729","id-type":"DOI","asserted-by":"publisher"}]},{"name":"S\u00f6derberg's Foundation"},{"name":"Pharmacist Hedberg's Foundation"},{"name":"University of G\u00f6teborg"},{"name":"Family Th\u00f6len and Kristlers Foundation"},{"name":"European Union Commission"},{"name":"Regional Agreement on Medical Training and Clinical Research"},{"name":"Western G\u00f6taland County Council"},{"name":"University of G\u00f6teborg"},{"DOI":"10.13039\/501100008106","name":"Reumatikerdistriktet I G\u00f6teborg","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008106","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,7,19]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>TKs are intracellular signaling molecules essential for cell homeostasis. Inhibition of TKs is used in treatment of malignancies and diabetes mellitus. The present study evaluated the role of Flt3 in antigen-induced arthritis. Mice were immunized with mBSA, and arthritis was induced by an i.a. injection of mBSA. Treatment with the Flt3 inhibitor sunitinib was started together with mBSA immunization or together with the induction of arthritis. The mBSA-injected joints were evaluated morphologically for signs of synovitis and bone\/cartilage destruction. Markers of bone metabolism and antibody responses were measured by ELISA. Maturation of DCs in the bone marrow and spleen was evaluated by flow cytometry. Sunitinib treatment reduced the intensity of synovitis and the incidence of bone destruction. The reduction in bone destruction was seen when the treatment was started at the time of immunization or at the time of arthritis induction. The antiarthritic effect was achieved by inhibition of DCs, reduction of antibody production, and bone metabolism. Inhibition of Flt3 is a potent antiarthritic mechanism reducing antigen presentation, synovial inflammation, and bone resorption. Down-regulation of TKs may be a useful tool in the treatment of human RA.<\/jats:p>","DOI":"10.1189\/jlb.1110640","type":"journal-article","created":{"date-parts":[[2011,7,20]],"date-time":"2011-07-20T03:09:43Z","timestamp":1311131383000},"page":"811-817","source":"Crossref","is-referenced-by-count":28,"title":["Inhibition of fms-like tyrosine kinase 3 alleviates experimental arthritis by reducing formation of dendritic cells and antigen presentation"],"prefix":"10.1093","volume":"90","author":[{"given":"Mats","family":"Dehlin","sequence":"first","affiliation":[{"name":"Department of Rheumatology and Inflammation Research, Sahlgrenska University Hospital, University of G\u00f6teborg , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Andersson","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Inflammation Research, Sahlgrenska University Hospital, University of G\u00f6teborg , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malin","family":"Erlandsson","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Inflammation Research, Sahlgrenska University Hospital, University of G\u00f6teborg , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael","family":"Brisslert","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Inflammation Research, Sahlgrenska University Hospital, University of G\u00f6teborg , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Bokarewa","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Inflammation Research, Sahlgrenska University Hospital, University of G\u00f6teborg , Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,7,19]]},"reference":[{"key":"2023033004530834200_","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature01661","article-title":"Evolving concepts of rheumatoid arthritis","volume":"423","author":"Firestein","year":"2003","journal-title":"Nature"},{"key":"2023033004530834200_","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1146\/annurev.biochem.69.1.373","article-title":"Protein tyrosine kinase structure and function","volume":"69","author":"Hubbard","year":"2000","journal-title":"Annu. Rev. Biochem."},{"key":"2023033004530834200_","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nrrheum.2009.82","article-title":"Tyrosine kinases as targets for the treatment of rheumatoid arthritis","volume":"5","author":"D'Aura Swanson","year":"2009","journal-title":"Nat. Rev. Rheumatol."},{"key":"2023033004530834200_","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1136\/ard.2004.029835","article-title":"Inhibition of c-kit tyrosine kinase by imatinib mesylate induces apoptosis in mast cells in rheumatoid synovia: a potential approach to the treatment of arthritis","volume":"64","author":"Juurikivi","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"2023033004530834200_","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1172\/JCI28546.","article-title":"Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritis","volume":"116","author":"Paniagua","year":"2006","journal-title":"J. Clin. Invest."},{"key":"2023033004530834200_","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1182\/blood-2006-04-016030","article-title":"Signaling of vascular endothelial growth factor receptor-1 tyrosine kinase promotes rheumatoid arthritis through activation of monocytes\/macrophages","volume":"108","author":"Murakami","year":"2006","journal-title":"Blood"},{"key":"2023033004530834200_","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00011-003-1230-4","article-title":"Angiogenesis inhibition by the novel VEGF receptor tyrosine kinase inhibitor, PTK787\/ZK222584, causes significant anti-arthritic effects in models of rheumatoid arthritis","volume":"53","author":"Grosios","year":"2004","journal-title":"Inflamm. Res."},{"key":"2023033004530834200_","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3109\/s10165-007-0592-9","article-title":"Imatinib mesylate both prevents and treats the arthritis induced by type II collagen antibody in mice","volume":"17","author":"Koyama","year":"2007","journal-title":"Mod. Rheumatol."},{"key":"2023033004530834200_","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s00774-006-0684-1","article-title":"Imatinib mesylate inhibits osteoclastogenesis and joint destruction in rats with collagen-induced arthritis (CIA)","volume":"24","author":"Ando","year":"2006","journal-title":"J. Bone Miner. Metab."},{"key":"2023033004530834200_","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1080\/07853890310001339","article-title":"Treatment of rheumatoid arthritis with imatinib mesylate: clinical improvement in three refractory cases","volume":"35","author":"Eklund","year":"2003","journal-title":"Ann. Med."},{"key":"2023033004530834200_","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3109\/08916930903374717","article-title":"Spleen tyrosine kinase: an Src family of non-receptor kinase has multiple functions and represents a valuable therapeutic target in the treatment of autoimmune and inflammatory diseases","volume":"43","author":"Ghosh","year":"2010","journal-title":"Autoimmunity"},{"key":"2023033004530834200_","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/0092-8674(91)90499-O","article-title":"Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice","volume":"64","author":"Soriano","year":"1991","journal-title":"Cell"},{"key":"2023033004530834200_","doi-asserted-by":"crossref","first-page":"17660","DOI":"10.1074\/jbc.M311032200","article-title":"Src kinase activity is essential for osteoclast function","volume":"279","author":"Miyazaki","year":"2004","journal-title":"J. Biol. Chem."},{"key":"2023033004530834200_","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1172\/JCI6093","article-title":"Suppression of arthritic bone destruction by adenovirus-mediated csk gene transfer to synoviocytes and osteoclasts","volume":"104","author":"Takayanagi","year":"1999","journal-title":"J. Clin. Invest."},{"key":"2023033004530834200_","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.clim.2007.03.543","article-title":"Inflammation and bone erosion are suppressed in models of rheumatoid arthritis following treatment with a novel Syk inhibitor","volume":"124","author":"Pine","year":"2007","journal-title":"Clin. Immunol."},{"key":"2023033004530834200_","first-page":"327","article-title":"In vivo antitumor activity of SU11248, a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor and platelet-derived growth factor receptors: determination of a pharmacokinetic\/pharmacodynamic relationship","volume":"9","author":"Mendel","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"2023033004530834200_","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/nrd2380","article-title":"Molecular basis for sunitinib efficacy and future clinical development","volume":"6","author":"Faivre","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"key":"2023033004530834200_","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1200\/JCO.2005.02.2194","article-title":"Safety, pharmacokinetic, and antitumor activity of SU11248, a novel oral multitarget tyrosine kinase inhibitor, in patients with cancer","volume":"24","author":"Faivre","year":"2006","journal-title":"J. Clin. Oncol."},{"key":"2023033004530834200_","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1182\/blood.V96.3.878","article-title":"In vivo generation of human dendritic cell subsets by Flt3 ligand","volume":"96","author":"Maraskovsky","year":"2000","journal-title":"Blood"},{"key":"2023033004530834200_","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/nm0697-625","article-title":"Flt3 ligand induces tumor regression and antitumor immune responses in vivo","volume":"3","author":"Lynch","year":"1997","journal-title":"Nat. Med."},{"key":"2023033004530834200_","first-page":"380","article-title":"FLT3 ligand administration inhibits tumor growth in murine melanoma and lymphoma","volume":"58","author":"Esche","year":"1998","journal-title":"Cancer Res."},{"key":"2023033004530834200_","doi-asserted-by":"crossref","first-page":"e3633","DOI":"10.1371\/journal.pone.0003633","article-title":"Intra-articular fms-like tyrosine kinase 3 ligand expression is a driving force in induction and progression of arthritis","volume":"3","author":"Dehlin","year":"2008","journal-title":"PLoS ONE"},{"key":"2023033004530834200_","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/art.1780200314","article-title":"Antigen-induced arthritis in mice. I. Induction of arthritis in various strains of mice","volume":"20","author":"Brackertz","year":"1977","journal-title":"Arthritis Rheum."},{"key":"2023033004530834200_","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00011-003-1182-8","article-title":"Genistein as an anti-inflammatory agent","volume":"52","author":"Verdrengh","year":"2003","journal-title":"Inflamm. Res."},{"key":"2023033004530834200_","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1073\/pnas.0608620104","article-title":"Ethanol prevents development of destructive arthritis","volume":"104","author":"Jonsson","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2023033004530834200_","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/ni1518","article-title":"Identification of clonogenic common Flt3+M-CSFR+ plasmacytoid and conventional dendritic cell progenitors in mouse bone marrow","volume":"8","author":"Onai","year":"2007","journal-title":"Nat. Immunol."},{"key":"2023033004530834200_","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/nri746","article-title":"Mouse and human dendritic cell subtypes","volume":"2","author":"Shortman","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"2023033004530834200_","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3","article-title":"The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide","volume":"43","author":"Schellekens","year":"2000","journal-title":"Arthritis Rheum."},{"key":"2023033004530834200_","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1128\/iai.65.7.2517-2521.1997","article-title":"Role of neutrophils in experimental septicemia and septic arthritis induced by Staphylococcus aureus","volume":"65","author":"Verdrengh","year":"1997","journal-title":"Infect. Immun."},{"key":"2023033004530834200_","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.4049\/jimmunol.148.7.2103","article-title":"Induction of arthritis with monoclonal antibodies to collagen","volume":"148","author":"Terato","year":"1992","journal-title":"J. Immunol."},{"key":"2023033004530834200_","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-3083.1990.tb02754.x","article-title":"Arthritis in DBA\/1 mice induced with passively transferred type II collagen immune serum. Immunohistopathology and serum levels of anti-type II collagen auto-antibodies","volume":"31","author":"Holmdahl","year":"1990","journal-title":"Scand. J. Immunol."},{"key":"2023033004530834200_","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.humimm.2009.02.006","article-title":"Dendritic cells in rheumatoid arthritis: which subset should be used as a tool to induce tolerance?","volume":"70","author":"Lebre","year":"2009","journal-title":"Hum. Immunol."},{"key":"2023033004530834200_","doi-asserted-by":"crossref","first-page":"7140","DOI":"10.4049\/jimmunol.0901175","article-title":"Plasmacytoid dendritic cells regulate autoreactive B cell activation via soluble factors and in a cell-to-cell contact manner","volume":"183","author":"Ding","year":"2009","journal-title":"J. Immunol."},{"key":"2023033004530834200_","doi-asserted-by":"crossref","first-page":"807","DOI":"10.4049\/jimmunol.0902528","article-title":"PDCA expression by B lymphocytes reveals important functional attributes","volume":"184","author":"Vinay","year":"2010","journal-title":"J. Immunol."},{"key":"2023033004530834200_","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.0105-2896.2009.00879.x","article-title":"Origin and development of dendritic cells","volume":"234","author":"Liu","year":"2010","journal-title":"Immunol. Rev."},{"key":"2023033004530834200_","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.4049\/jimmunol.175.6.3674","article-title":"Inhibition of natural type I IFN-producing and dendritic cell development by a small molecule receptor tyrosine kinase inhibitor with Flt3 affinity","volume":"175","author":"Tussiwand","year":"2005","journal-title":"J. Immunol."},{"key":"2023033004530834200_","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1084\/jem.20021263","article-title":"ICSBP is essential for the development of mouse type I interferon-producing cells and for the generation and activation of CD8\u03b1(+) dendritic cells","volume":"196","author":"Schiavoni","year":"2002","journal-title":"J. Exp. Med."},{"key":"2023033004530834200_","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1084\/jem.20101459","article-title":"The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency","volume":"208","author":"Bigley","year":"2011","journal-title":"J. Exp. Med."},{"key":"2023033004530834200_","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1182\/blood-2004-10-3967","article-title":"Macrophage colony-stimulating factor receptor c-fms is a novel target of imatinib","volume":"105","author":"Dewar","year":"2005","journal-title":"Blood"}],"container-title":["Journal of Leukocyte Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1189%2Fjlb.1110640","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jleukbio\/article-pdf\/90\/4\/811\/49616954\/jlb0811.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jleukbio\/article-pdf\/90\/4\/811\/49616954\/jlb0811.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T06:21:07Z","timestamp":1686205267000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jleukbio\/article\/90\/4\/811\/6960423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,19]]},"references-count":39,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2011,7,19]]},"published-print":{"date-parts":[[2011,7,19]]}},"URL":"https:\/\/doi.org\/10.1189\/jlb.1110640","relation":{},"ISSN":["0741-5400","1938-3673"],"issn-type":[{"value":"0741-5400","type":"print"},{"value":"1938-3673","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2011,10]]},"published":{"date-parts":[[2011,7,19]]}}}